Antimicrobial activity of Substance P and Neuropeptide Y against laboratory strains of bacteria and oral microorganisms

被引:54
作者
Hansen, Christopher J.
Burnell, Kindra K.
Brogden, Kim A. [1 ]
机构
[1] Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52252 USA
[2] Univ Iowa, Coll Dent, Dow Inst Dent Res, Iowa City, IA 52252 USA
关键词
Substance P; Neuropeptide Y; innate immunity; antimicrobial activity;
D O I
10.1016/j.jneuroim.2006.05.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infection and inflammation of mucosal tissue may induce the production of neuropeptides, specifically Substance P and Neuropeptide Y. Since these neuropeptides are similar to antimicrobial peptides in their amino acid composition, amphipathic design, cationic charge, and size, we wanted to determine if they had antimicrobial activity against a panel of common bacteria and oral microorganisms using the radial diffusion assay. Neuropeptide Y and Substance P had antimicrobial activity against E. coli (MIC 20.6 +/- 5.5 mu g/ml SEM and 71.5 +/- 15 SEM mu g/ml, respectively), but did not have activity against laboratory strains of Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens (MIC > 500 mu g/ml) nor oral strains of Streptococcus mutans, Candida albicans, and Actinobacillus actinomycetemcomitans (MIC > 500 mu g/ml). While Substance P and Neuropeptide Y did not have direct antimicrobial activity against the microorganisms tested, they still may stimulate local epithelial cells to produce other innate immune factors like defensins and cathelicidins. However, this remains to be determined. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:215 / 218
页数:4
相关论文
共 33 条
[1]   Defining the normal bacterial flora of the oral cavity [J].
Aas, JA ;
Paster, BJ ;
Stokes, LN ;
Olsen, I ;
Dewhirst, FE .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (11) :5721-5732
[2]   Quantitative analysis of substance P, neurokinin A and calcitonin gene-related peptide in gingival crevicular fluid associated with painful human teeth [J].
Awawdeh, LA ;
Lundy, FT ;
Linden, GJ ;
Shaw, C ;
Kennedy, JG ;
Lamey, PJ .
EUROPEAN JOURNAL OF ORAL SCIENCES, 2002, 110 (03) :185-191
[3]   Neuropeptide Y and epilepsy: recent progress, prospects and controversies [J].
Baraban, SC .
NEUROPEPTIDES, 2004, 38 (04) :261-265
[4]   Relevance of Neuropeptide Y for the neuroimmune crosstalk [J].
Bedoui, S ;
Kawamura, N ;
Straub, RH ;
Pabst, R ;
Yamamura, T ;
von Hösten, S .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 134 (1-2) :1-11
[5]   The complex oral microflora of high-risk individuals and groups and its role in the caries process [J].
Beighton, D .
COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 2005, 33 (04) :248-255
[6]   Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? [J].
Brogden, KA .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) :238-250
[7]   The nervous system and innate immunity: the neuropeptide connection [J].
Brogden, KA ;
Guthmiller, JM ;
Salzet, M ;
Zasloff, M .
NATURE IMMUNOLOGY, 2005, 6 (06) :558-564
[8]   The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection [J].
Brogden, KA ;
Kalfa, VC ;
Ackermann, MR ;
Palmquist, DE ;
McCray, PB ;
Tack, BF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :331-334
[9]   Defensins: Antimicrobial peptides of innate immunity [J].
Ganz, T .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (09) :710-720
[10]   Susceptibilities of oral bacteria and yeast to mammalian cathelicidins [J].
Guthmiller, JM ;
Vargas, KG ;
Srikantha, R ;
Schomberg, LL ;
Weistroffer, PL ;
McCray, PB ;
Tack, BF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) :3216-3219